Skip to content

Add your earlier progress to your account?

From before you signed in, this browser has:

Which plan do you want to keep?

You answered the plan questions before signing in. These answers differ from the plan saved on your account.

SettingSaved planNew answers

Study progress is waiting to be saved

ChemistryLesson 15 of 17

Vitamins and Nutrition

  • 24 min
  • 12 sections
  • 3 self-checks
On this page

A vitamin result describes the compartment that was sampled, and that compartment may not represent the body's overall supply. Serum, plasma, whole blood, and erythrocytes reflect different compartments, and in one patient their results can disagree. 25-hydroxyvitamin D reflects supply over weeks. 1,25-dihydroxyvitamin D turns over within hours. Serum retinol stays within its interval until hepatic stores are nearly exhausted. A total serum cobalamin inside its reference interval does not exclude deficiency inside the cell, which is why the metabolite methylmalonic acid is measured when the serum value is equivocal. Several of these analytes also fall during inflammation with no change in intake, and a few degrade in the tube before analysis. Interpreting a result therefore means identifying which compartment was sampled, whether the specimen was collected and stored well enough to represent it, and whether something other than nutrition changed the value.1

Three ways to measure a vitamin

Direct measurement quantifies the vitamin or its active form. It dominates current practice, and liquid chromatography with tandem mass spectrometry (LC-MS/MS) has displaced most of the older high-performance liquid chromatography (HPLC), microbiologic, and spectrophotometric procedures for these analytes, though HPLC remains in service for the tocopherols and immunoassay for cobalamin, folate, and routine 25-hydroxyvitamin D.1

Functional measurement quantifies a vitamin-dependent enzyme activity, usually as an activation coefficient: the enzyme is assayed with and without added cofactor, and a large increase on addition means the cell was short of cofactor. Erythrocyte transketolase for thiamine and erythrocyte glutathione reductase for riboflavin both work this way. Functional tests reflect cellular status, which is their advantage and also why they are hard to standardize. The glutathione reductase coefficient cannot be interpreted in glucose-6-phosphate dehydrogenase deficiency, because the enzyme system it measures is already abnormal.1

Metabolite measurement quantifies a substrate that accumulates when the dependent reaction slows. Methylmalonic acid and total homocysteine serve this role for cobalamin and folate. A metabolite reflects intracellular sufficiency only when nothing else in the patient raises the same metabolite, which limits interpretation of both markers.1

Load and saturation tests, in which a dose is given and urinary excretion measured afterward, are historical research methods and are no longer offered clinically.

Status tests by vitamin

Vitamin D, cobalamin, and folate have their own sections below. Intervals in the table come from published national reference laboratory catalogs so that magnitude and units are concrete. Each interval applies to its stated method. Interpret patient results with the performing laboratory's verified values and report comments.2,3

Vitamin Deficiency presentation Status measurement and representative adult interval Chief interpretive limit
A (retinol) Night blindness, xerophthalmia, follicular hyperkeratosis, impaired immunity Serum retinol by HPLC or LC-MS/MS; fasting specimen, centrifuged within 2 hours into a light-protected vial; 32.5–78.0 µg/dL at age 18 and older3 Hepatic stores keep serum retinol steady until they are nearly exhausted, so a value within the interval does not exclude depletion. Inflammation lowers retinol and retinol-binding protein independent of stores. About 20 µg/dL is the threshold for considering deficiency and 10 µg/dL for severe deficiency. These are decision limits3
E (alpha-tocopherol) Hemolytic anemia in premature infants, peripheral neuropathy, ataxia, myopathy Serum alpha- and gamma-tocopherol by HPLC; alpha-tocopherol 5.5–18.0 mg/L at age 13 and older, gamma-tocopherol 0–6.0 mg/L2 Tocopherol travels on lipoproteins, so hyperlipidemia raises the concentration and low circulating lipid lowers it. Express the result against total lipid when lipids are abnormal: below about 0.8 mg alpha-tocopherol per gram of total lipid indicates adult deficiency4
K Bleeding and easy bruising; hemorrhagic disease of the newborn Functional tests: prothrombin time and PIVKA-II. Serum phylloquinone by LC-MS/MS exists but reflects recent intake See Vitamin K and carboxylation below
B1 (thiamine) Wet and dry beriberi, Wernicke encephalopathy, refeeding decompensation ARUP whole-blood thiamine diphosphate by LC-MS/MS; unseparated heparin or EDTA whole blood, frozen within 1 hour of collection; 70–180 nmol/L2 Thiamine diphosphate is carried inside erythrocytes, so serum and plasma miss most of the pool and are rejected for this whole-blood assay2
B2 (riboflavin) Angular stomatitis, cheilosis, glossitis, seborrheic dermatitis Erythrocyte glutathione reductase activation coefficient, where available Not routinely measured, poorly standardized, and invalid in glucose-6-phosphate dehydrogenase deficiency. Riboflavin is markedly photolabile1
B3 (niacin) Pellagra: dermatitis, diarrhea, dementia No routine clinical status test; urinary methylated metabolites are used in nutrition surveys Blood niacin concentration is not a reliable status indicator, and pellagra is recognized clinically. Pharmacologic niacin doses alter the lipid panel1
B5 (pantothenic acid) Not encountered in isolation No validated routine status test Isolated deficiency is seen only in experimental depletion studies
B6 (pyridoxine) Seizures in infants, sideroblastic anemia, dermatitis, peripheral neuropathy Plasma pyridoxal 5'-phosphate by HPLC with fluorescence detection or LC-MS/MS; separated within 1 hour into an amber tube, transported frozen, 8-hour fast preferred; 20.0–125.0 nmol/L2 Pyridoxal 5'-phosphate falls during inflammation independent of intake.4 Isoniazid, cycloserine, penicillamine, and hydralazine antagonize the vitamin, and because alkaline phosphatase dephosphorylates the analyte it rises in hypophosphatasia1
B7 (biotin) Alopecia, periorificial dermatitis, seizures; raw egg-white avidin binding is the classic dietary cause No routine clinical status test For the laboratory, biotin is an interference problem. High-dose supplements saturate streptavidin-biotin assay chemistry, and FDA names falsely low troponin as a patient-safety hazard5
C (ascorbic acid) Scurvy: perifollicular hemorrhage, gingival bleeding, poor wound healing Plasma ascorbate by HPLC or LC-MS/MS; heparin plasma into an ice bath at collection, light protected, separated and frozen within 1 hour into an amber tube2 The most labile analyte in this group: ambient and refrigerated specimens are unacceptable, and EDTA plasma and gross hemolysis are rejected. Urinary ascorbate reflects recent intake and does not reflect tissue stores2,1

Inflammation changes several of these analytes at once. Retinol, retinol-binding protein, and pyridoxal 5'-phosphate all fall during an acute-phase response with no change in intake.4 Population surveys handle that by measuring C-reactive protein and alpha-1-acid glycoprotein alongside the nutrient and correcting by regression, the approach the Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia project developed and validated for retinol-binding protein. Those corrections estimate deficiency prevalence across a survey and are not per-patient correction factors.6 For individual results, report a low nutrient marker together with an inflammatory marker.

Specimen handling and light protection

Most errors in these assays occur before analysis. Recollect a degraded specimen, because no calculation can recover an analyte that oxidized in the tube.1

Light protection is analyte-specific and method-specific. On ARUP Laboratories' menu, pyridoxal 5'-phosphate, ascorbate, and erythrocyte folate require protection from light. 25-hydroxyvitamin D does not, and it tolerates 24 hours at ambient temperature.2 Serum retinol at another national laboratory is transferred to a light-protected vial and is then stable for 28 days refrigerated.3 CDC's folate procedure states the size of the effect: folate exposed to light for more than 8 hours can degrade by 10 to 20%, which is why that laboratory processes folate specimens under yellow light and freezes them promptly when analysis is not immediate.7 Follow each assay's own procedure.

Temperature and elapsed time also affect stability. Ascorbate is stable only when frozen. For ARUP's whole-blood thiamine diphosphate assay, the specimen must be frozen within 1 hour of collection. Refrigerated and room-temperature specimens are unacceptable for that assay. Frozen stability is 6 months. Methylmalonic acid requires separation within about 2 hours and frozen transport, with room-temperature specimens unacceptable.2 Fasting also matters: nonfasting pyridoxal 5'-phosphate and retinol can reflect the last meal or dose more than status, and any nutrient measured after replacement has begun reflects the replacement.2,3

Vitamin D status testing

25-hydroxyvitamin D is the status analyte, with a half-life of 2 to 3 weeks that reflects combined supply from skin synthesis, diet, and supplements. 1,25-dihydroxyvitamin D has a half-life near 4 hours, is kept within its reference interval by parathyroid hormone, calcium, and phosphate, and is often normal or high in a frankly deficient patient.8 The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Committee on Bone Metabolism limits its use to specific indications: working up hypercalcemia, evaluating calcipenic rickets and osteomalacia, and separating those from FGF23-mediated phosphopenic rickets. It is not recommended for routine monitoring in chronic kidney disease, no reference measurement procedure exists for it, and the automated immunoassays that measure it do not resolve the D2 and D3 forms.9 One catalog reports it by chemiluminescent immunoassay at 19.9 to 79.3 pg/mL and states that it is not an assessment of vitamin D deficiency.2 Synthesis, activation, and the parathyroid relationship are covered in the parathyroid and vitamin D lesson.

The reference measurement system. CDC's Vitamin D Reference Laboratory operates a higher-order procedure for total 25-hydroxyvitamin D that quantifies the D2 and D3 forms separately by liquid chromatography with tandem mass spectrometry, is unaffected by other isomers including C3-epi-25-OH-D3, is calibrated against NIST standard reference material SRM 2972a, and has a maximum allowable bias of 1.7% with 5% imprecision.10 The published candidate procedure uses isotope dilution on a pentafluorophenylpropyl phase to obtain baseline separation of 25-OH-D2 and 25-OH-D3 from the C3 isomers, which is most important in infants, in whom the epimer makes up the largest share of measured D3.11

These programs have different purposes. The NIH Office of Dietary Supplements established the Vitamin D Standardization Program in 2010 and coordinated it through 2018. NIST and Ghent University supplied the independent reference measurement procedures recognized by the Joint Committee for Traceability in Laboratory Medicine.12 CDC runs the Vitamin D Standardization-Certification Program, which certifies routine total 25-OH-D assays with mean bias within 5% and imprecision below 10%.13

Immunoassay against LC-MS/MS. An automated immunoassay reports one total value from antibody binding after the analyte is released from vitamin D binding protein, and antibodies do not recognize the D2 and D3 forms equally. That unequal cross-reactivity is the main reason two methods disagree on one specimen, and it matters most in a patient taking ergocalciferol. A published comparison of automated immunoassays against LC-MS/MS found method-dependent bias across platforms and poor agreement with total 25-OH-D for one assay that measured only the D3 form.14 Keep serial results for one patient on one method.

Binding protein and free fractions. Less than 0.1% of 25-OH-D circulates free, and the bioavailable fraction is the free plus albumin-bound portion. Both can be calculated from total 25-OH-D, albumin, and binding protein. Routine free or bioavailable measurement is not recommended, because those assays lack standardization and agreed reference data. Pregnancy, liver disease, nephrotic syndrome, and critical illness shift binding protein and therefore shift total 25-OH-D without necessarily changing the free fraction.9

The cutoffs are decision limits, and they are contested. The 2011 Endocrine Society guideline defined deficiency below 20 ng/mL and insufficiency at 21 to 29 ng/mL, and 20 ng/mL remains a common laboratory cutoff.8 The 2011 Institute of Medicine dietary reference intake report used the same number for a different purpose, as the concentration meeting the requirement of nearly all people under minimal sun exposure, which is a population intake benchmark.15 The 2024 Endocrine Society guideline found no trial evidence defining an optimal target and suggests against routine 25-OH-D testing in generally healthy adults who have no established indication, and it sets no sufficiency thresholds for that population.16 Converting units uses the 400.6 g/mol molar mass of 25-hydroxyvitamin D3: 1 ng/mL is about 2.5 nmol/L.

Cobalamin and folate

Routine serum cobalamin and folate are competitive-binding chemiluminescent or electrochemiluminescent immunoassays. The cobalamin assay uses intrinsic factor as the binding protein and the folate assay uses folate-binding protein. Radioassay formats are no longer used.1,2

The intrinsic-factor design has a specific failure mode. A patient with pernicious anemia may carry anti-intrinsic-factor antibody that interferes with the assay's own intrinsic factor reagent and gives a normal or high total cobalamin in a profoundly deficient patient. Reagent formulations are designed to suppress the effect, and it has still been reported repeatedly.17,18 A normal total cobalamin therefore does not exclude deficiency when the blood film, the clinical picture, or the metabolites disagree with it. Repeat on a different assay design, and measure methylmalonic acid.19

Cobalamin and folate test selection. The College of American Pathologists (CAP) test-ordering guidance directs total cobalamin for anemia or new neurologic signs without an alternative explanation, alongside a complete blood count (CBC), reticulocyte count, lactate dehydrogenase (LDH), haptoglobin, bilirubin, and a blood-film review. Total folate is ordered only when the history supports a deficient diet or a malabsorptive comorbidity. When either concentration is borderline or discordant with clinical judgment, the metabolites are measured next: methylmalonic acid and homocysteine for cobalamin, homocysteine for folate, with intrinsic-factor antibody to confirm pernicious anemia. The guidance lists three tests as rarely indicated: serum folate in a patient with an adequate diet and no malabsorption, erythrocyte folate, and active cobalamin.20

Methylmalonic acid rises in intracellular cobalamin deficiency and stays normal in isolated folate deficiency, so it distinguishes the two deficiencies.20 Renal impairment is the dominant non-nutritional cause of elevation, with age, hypovolemia, and small intestinal bacterial overgrowth contributing, so interpret an elevated value with renal function.19 One catalog measures it by LC-MS/MS with an interval of 0.00 to 0.40 µmol/L.2

Total homocysteine rises in both deficiencies, and also in vitamin B6 deficiency, renal failure, hypothyroidism, and common MTHFR variants, so it is the less specific of the two.20,19 Its preanalytic requirement is strict and frequently missed: erythrocytes keep exporting homocysteine into plasma after collection, so place whole blood on wet ice and separate plasma promptly. One national laboratory allows up to 4 hours only if the specimen stays on wet ice continuously, and 1 hour otherwise. A delayed, unchilled specimen produces a falsely elevated result that can be mistaken for disease.3

Serum against erythrocyte folate. Serum folate indicates short-term status and erythrocyte folate long-term status, because folate enters the red cell during erythropoiesis and stays for the cell's life.7 Hemolysis falsely raises serum folate, because erythrocytes hold far more folate than plasma does, so interpret a hemolyzed specimen with caution or reject it. Never report it at face value.7 Erythrocyte folate measurement depends on that same gradient, which also makes it difficult to perform. In CDC's survey method, one part fresh EDTA whole blood is diluted with ten parts 1% ascorbic acid, a 1 in 11 hemolysate that is frozen promptly to hold folate in the reduced state, and a hematocrit is measured at the time of collection for the calculation.7 The reported erythrocyte folate is a calculated value.

Suppose whole-blood folate, already corrected for the method's hemolysate dilution, is 300 µg/L, serum folate on the same draw is 8 µg/L, and hematocrit is 0.40.

erythrocyte folate = [whole-blood folate − serum folate × (1 − Hct)] ÷ Hct

erythrocyte folate = [300 µg/L − (8 µg/L × 0.60)] ÷ 0.40 = 295.2 µg/L ÷ 0.40 = 738 µg/L

The subtraction removes the folate contributed by the non-erythrocyte fraction and the division converts the remainder to a per-red-cell concentration. The result combines three separate measurements and one method-specific dilution factor, each with its own imprecision, and the hematocrit must come from the same draw. The combined imprecision brings no matching gain in diagnostic value, so serum folate is the routine test.20,7

Folate testing changed after US grain fortification. FDA's final rule required folic acid in enriched cereal-grain products, with compliance from January 1, 1998.21 Deficiency became uncommon enough that CAP states it is not necessary to measure folate in a patient with an adequate diet and no evidence of malabsorption.20

Antibodies help explain the cause of cobalamin deficiency. Intrinsic-factor antibody is highly specific for pernicious anemia and insensitive, so a negative result does not exclude it. Gastric parietal-cell antibody is more sensitive and much less specific. The limited performance of both, together with the absence of a robust absorption test since radiolabeled cobalamin studies left service, is why the cause of a depleted cobalamin status is now inferred from antibodies and history.19 The National Institute for Health and Care Excellence (NICE) guideline NG239 treats an indeterminate total or active cobalamin as unresolved pending further testing, directs that the laboratory's own validated reference range applies to a methylmalonic acid result, notes that some antibody tests are unreliable after a recent cobalamin injection, and advises collecting before replacement whenever that does not delay treatment for megaloblastic anemia or neurologic signs. NG239 is United Kingdom guidance. A United States laboratory reports against its own verified interval and its own indeterminate-zone comment.22

Recent supplementation, transfusion, and food intake can change the interpretation of cobalamin or folate results. Record their timing. Supplementation may raise the measured concentration before a deficiency is fully corrected, transfusion can obscure the untreated baseline, and recent intake particularly affects serum folate. Obtain pretreatment specimens when clinically appropriate and interpret or repeat testing according to the assay and clinical question.1 Nitrous oxide inactivates cobalamin without changing the blood concentration, and it raises homocysteine and methylmalonic acid.20 Folate repletion can correct the anemia of cobalamin deficiency while demyelinating injury continues, so cobalamin status is measured together with folate.20,19

Vitamin K and carboxylation

Vitamin K is the cofactor for hepatic gamma-carboxylation of factors II, VII, IX, and X and of proteins C and S. Warfarin inhibits the same vitamin K cycle, so check the anticoagulant history before reading any result as nutritional.1

The prothrombin time is an accessible but nonspecific functional index. It responds only after factor activity has fallen substantially, so it detects established depletion and misses developing deficiency, and it changes for many reasons unrelated to vitamin K.1 PIVKA-II, protein induced by vitamin K absence or antagonism-II, is the undercarboxylated prothrombin also called des-gamma-carboxyprothrombin, and it appears earlier because it reflects the carboxylation defect directly. Its non-nutritional causes limit interpretation: warfarin, cholestasis, parenchymal liver disease, and hepatocellular carcinoma all raise it, and its dominant published use is as a hepatocellular carcinoma marker interpreted with other biomarkers.23 Direct phylloquinone measurement exists and reflects recent intake more than status.

Serum proteins are not nutrition markers

Albumin has a half-life of about 20 days, transferrin 8 days, transthyretin (reported as prealbumin) 2 to 3 days, and retinol-binding protein roughly 12 hours. All four are negative acute-phase proteins whose concentrations fall with inflammation regardless of intake. The American Society for Parenteral and Enteral Nutrition (ASPEN) interprets these proteins as indicators of inflammation and the risk of an adverse outcome.24 They are unsuitable as nutrition markers or proxies for total body protein or muscle mass, are excluded from malnutrition definitions, and have no defined role in monitoring the delivery or efficacy of nutrition support.25 In hospitalized adults receiving enteral nutrition, prealbumin change correlated with change in C-reactive protein and did not differ between patients meeting at least 60% of calorie needs and those falling short.26 The Society of Critical Care Medicine (SCCM) and ASPEN guideline states that these proteins are not validated for assessing protein adequacy in critical illness.27

Each protein has distinct confounders. Albumin falls with hepatic disease, nephrotic syndrome, protein-losing enteropathy, capillary leak, and dilution, and it rises artifactually with venous stasis, measurably within a few minutes of tourniquet application.28 Transferrin concentration rises in iron deficiency, so a high transferrin can reflect iron depletion with no change in nutritional status. Iron studies are explained in the anemia lesson.1 Prealbumin and transferrin are measured by quantitative immunoturbidimetry or immunonephelometry, and catalog intervals are method- and age-specific: one laboratory reports prealbumin at 20 to 40 mg/dL, transferrin at 200 to 360 mg/dL, and retinol-binding protein at 3.0 to 6.0 mg/dL.2

No laboratory value diagnoses malnutrition. Under the Global Leadership Initiative on Malnutrition criteria, a patient screened at risk requires at least one phenotypic criterion, unintentional weight loss, low body mass index, or reduced muscle mass, together with at least one etiologic criterion, reduced intake or assimilation or disease burden with inflammation, and severity is graded from the phenotypic criteria. C-reactive protein appears only as a supportive measure for the inflammation criterion, never as a criterion itself.29 The Academy of Nutrition and Dietetics and ASPEN consensus is built the same way, on two or more of six clinical characteristics: insufficient energy intake, weight loss, loss of muscle mass, loss of subcutaneous fat, fluid accumulation, and diminished grip strength. Serum proteins are not among them.30

The laboratory's role is narrower. It identifies a specific micronutrient deficiency and provides the C-reactive protein needed to interpret a low nutrient marker.4 It also supplies the serial results used to detect refeeding syndrome. ASPEN defines the syndrome by a 10 to 20%, 20 to 30%, or greater than 30% fall in serum phosphate, potassium, or magnesium within 5 days of reintroducing calories and recommends baseline testing with repeat measurement every 12 hours through the first 3 days in high-risk adults. A thiamine concentration is not used to decide urgent clinical replacement. The nutrition service is responsible for feeding and replacement decisions.31 Nitrogen balance from a timed urine urea nitrogen collection remains orderable, with one laboratory's excretion interval of 12.0 to 20.0 g/day. The calculation requires a complete collection and an accurate intake record, and an error in either invalidates it.2

Interference to rule out before reporting

Interference Effect on the result Laboratory response
High-dose biotin Competes with the biotinylated reagent for streptavidin, shifting results in a direction set by the assay design5 Ask about supplements, repeat after the washout the insert defines, or use a platform that does not rely on the streptavidin-biotin pair. The endocrine methods lesson covers the mechanism
Anti-intrinsic-factor antibody Normal or elevated total cobalamin in a deficient patient on intrinsic-factor-based competitive assays17,18 Repeat on a different assay design and measure methylmalonic acid
Hemolysis Falsely raises serum folate; gross hemolysis also disqualifies an ascorbate specimen7,2 Recollect; do not correct arithmetically
Inflammation Lowers retinol, retinol-binding protein, transthyretin, albumin, and pyridoxal 5'-phosphate independent of intake4 Report C-reactive protein alongside the nutrient marker
Renal impairment Raises methylmalonic acid and total homocysteine without cobalamin deficiency19 Interpret against renal function and the laboratory's own interval
Recent supplementation, transfusion, or intake The result reflects the replacement or the donor unit1 Record timing at the draw and collect baseline specimens first where clinically safe
Ergocalciferol therapy Immunoassay 25-OH-D results vary with how well the antibody recognizes the D2 form14 Prefer a method reporting D2 and D3 separately, and keep serial results on one method
Venous stasis Raises measured albumin within minutes of tourniquet application28 Standardize tourniquet time

Reference intervals, decision limits, and comparability

Among the analytes here, 25-hydroxyvitamin D has the most developed standardization system, with a certification program, a higher-order reference procedure, and NIST reference material behind it.10,13 Folate has certified reference materials as well: the National Institute for Biological Standards and Control (NIBSC) supplies a WHO reference material for serum folate certified by LC-MS/MS and one for whole-blood folate whose value is consensus-assigned and mainly representative of the microbiologic assay, which is itself a caution about transferring whole-blood folate values across methods.7 For most of the remaining analytes, results are method-specific, and alpha-tocopherol, thiamine diphosphate, and total cobalamin each have their own interval. Keep serial monitoring in the same laboratory on the same method.2

Under the Clinical Laboratory Improvement Amendments (CLIA), a laboratory using an unmodified FDA-cleared or approved nonwaived system verifies accuracy, precision, and reportable range, and confirms that the manufacturer's reference interval fits its own specimen type and patient demographics before reporting. A modified system, one that is not cleared, or one whose manufacturer specifies no interval requires the laboratory to establish the interval itself, and either activity is documented.32 The quality control lesson covers the general calibration and control program.

A nutritional test report may include both a reference interval and a decision limit. The interval describes values in a healthy reference population tested by one method. The decision limit marks a threshold for action. The report needs to distinguish them even when they appear side by side. The 20 ng/mL vitamin D cutoff, the 20 and 10 µg/dL retinol thresholds, and a folate adequacy cutoff are decision limits. The tocopherol, thiamine diphosphate, and pyridoxal 5'-phosphate ranges above are reference intervals.15,16

Tests with limited or question-specific use

Test Status
Serum or plasma thiamine The analyte of interest is intracellular, so these specimens are rejected in favor of whole-blood thiamine diphosphate2
Blood niacin concentration Not a reliable indicator of niacin status1
Urinary ascorbate and ascorbate saturation loading Reflect recent intake and do not reflect tissue stores1
Erythrocyte transketolase and glutathione reductase activation coefficients Functional assays that are labor-intensive and poorly standardized, and the riboflavin coefficient is invalid in glucose-6-phosphate dehydrogenase deficiency1
Tryptophan load and erythrocyte aminotransferase activation coefficients Historical vitamin B6 functional assays superseded by plasma pyridoxal 5'-phosphate1
1,25-dihydroxyvitamin D as a status test Wrong analyte for the question, and often normal or elevated in deficiency8,9
Radiolabeled cobalamin absorption testing No robust absorption test remains in service, which is part of why cause is inferred from antibodies and history19
Erythrocyte folate The US CAP test-ordering guide favors serum folate for most evaluations and lists erythrocyte folate as rarely indicated. Select testing for the clinical question and local pathway.20
Active cobalamin (holotranscobalamin) Use depends on availability and the testing pathway. UK NICE NG239 includes total or active B12 for initial testing and recommends active B12 during pregnancy. It is not an obsolete analyte.22,33
Serum folate in a patient with an adequate diet and no malabsorption Unnecessary given the low prevalence of deficiency after grain fortification20
Albumin, prealbumin, transferrin, and retinol-binding protein as nutrition markers Reflect inflammation and outcome risk; unsuitable for assessing nutritional status24,25
Nitrogen balance and the creatinine-height index as malnutrition criteria Neither is a diagnostic criterion, and both depend on collection completeness27,29
Commercial hair and nail nutrient panels Cannot separate external contamination from incorporated content; covered in trace elements

An undirected multivitamin panel is also inappropriate. Each analyte in it has its own specimen, timing, and inflammation requirements, so results from a panel ordered without a clinical question cannot be interpreted. Start every vitamin request from the clinical question, then choose the compartment and specimen that fit it.

Vitamin D synthesis, activation, and the parathyroid relationship are covered in the parathyroid and vitamin D lesson. Megaloblastic morphology and the metabolic trap linking cobalamin and folate are in the anemia lesson. Biotin interference in immunoassay design is covered in endocrine methods. Albumin and prealbumin methods, dye-binding bias, and the electrophoretic fractions are in plasma proteins. Essential trace elements and contamination-free collection are in trace elements. Ascorbate interference with reagent-strip chemistry is in urine reagent strips. Cross-discipline interval comparison is in clinical reference intervals.

Practice

Check yourself 1 of 3

An erythrocyte enzyme is measured with and without added vitamin cofactor. A large activity increase after addition indicates which principle?

Incorrect. Direct measurement quantifies the vitamin or its active form in the specimen. An activation coefficient describes an enzyme's response inside the cell.

Correct. A large increase when cofactor is added means the cell was deficient in the cofactor. Erythrocyte transketolase for thiamine and glutathione reductase for riboflavin work this way.

Incorrect. A metabolite assay quantifies a substrate that accumulates when a vitamin-dependent reaction slows, such as methylmalonic acid. This test measures an enzyme's response to added cofactor.

Review this section

Check yourself 2 of 3

When vitamin D status testing is indicated, which analyte ordinarily reflects combined supply from skin, diet, and supplements?

Incorrect. Its half-life is about 4 hours, and PTH, calcium, and phosphate keep it tightly regulated, so it can be normal or high in a deficient patient.

Incorrect. Free and bioavailable 25-hydroxyvitamin D assays lack standardization and agreed reference data, so routine measurement is not recommended.

Correct. With a half-life of 2 to 3 weeks, it reflects combined supply from skin, diet, and supplements, so it is the analyte used to assess status. Keep serial results on one method.

Review this section

Check yourself 3 of 3

During enteral feeding, prealbumin rises from 10 to 18 mg/dL as C-reactive protein falls. What does the prealbumin rise most directly reflect?

Incorrect. A short half-life only means the concentration can change quickly. In enteral-feeding patients, prealbumin change followed C-reactive protein and did not differ with the share of calorie needs met.

Correct. Prealbumin is a negative acute-phase protein, so it falls during inflammation and recovers as inflammation resolves, regardless of intake. Report it with C-reactive protein, and judge malnutrition by its clinical criteria.

Incorrect. ASPEN states that these serum proteins should not be used as proxies for total body protein or muscle mass.

Review this section

References
  1. Rifai N, Chiu RWK, Young I, Burnham CAD, Wittwer CT, eds. Tietz Textbook of Laboratory Medicine. 7th ed. Elsevier; 2023. Back to text
  2. ARUP Laboratories test directory. Vitamin B1 (thiamine), whole blood; vitamin B6 (pyridoxal 5-phosphate); vitamin C (ascorbic acid), plasma; vitamin E, serum or plasma; 25-hydroxyvitamin D2 and D3 by tandem mass spectrometry, serum and plasma; vitamin D, 1,25-dihydroxy; vitamin B12; folate, serum; folate, RBC; methylmalonic acid, serum or plasma (vitamin B12 status); homocysteine, total; prealbumin, serum; transferrin, serum; retinol binding protein; urea nitrogen, urine. Thiamine entry accessed September 5, 2026; other entries accessed August 31, 2026. Catalog methods, specimen requirements, and reference intervals are laboratory- and method-specific. Back to text
  3. Mayo Clinic Laboratories test catalog. Vitamin A, serum; homocysteine, total, plasma. Accessed September 7, 2026. Back to text
  4. Berger MM, Shenkin A, Schweinlin A, et al. ESPEN micronutrient guideline. Clin Nutr. 2022;41(6):1357-1424. doi:10.1016/j.clnu.2022.02.015 Back to text
  5. US Food and Drug Administration. Testing for Biotin Interference in In Vitro Diagnostic Devices: Guidance for Industry. US Food and Drug Administration; October 2020. Accessed September 27, 2026. fda.gov/media/127915/download Back to text
  6. Larson LM, Namaste SML, Williams AM, et al. Adjusting retinol-binding protein concentrations for inflammation: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project. Am J Clin Nutr. 2017;106(suppl 1):390S-401S. doi:10.3945/ajcn.116.142166 Back to text
  7. Centers for Disease Control and Prevention, Division of Laboratory Sciences. Laboratory procedure manual: total folate in serum and whole blood, microbiologic assay. NHANES 2021-2022. Accessed August 31, 2026. Back to text
  8. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930. doi:10.1210/jc.2011-0385 Back to text
  9. Makris K, Bhattoa HP, Cavalier E, et al. Recommendations on the measurement and the clinical use of vitamin D metabolites and vitamin D binding protein: a position paper from the IFCC Committee on Bone Metabolism. Clin Chim Acta. 2021;517:171-197. doi:10.1016/j.cca.2021.03.002 Back to text
  10. Centers for Disease Control and Prevention. Vitamin D reference laboratory. Clinical Standardization Programs. Reviewed April 24, 2024. Accessed August 31, 2026. Back to text
  11. Mineva EM, Schleicher RL, Chaudhary-Webb M, et al. A candidate reference measurement procedure for quantifying serum concentrations of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 using isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2015;407(19):5615-5624. doi:10.1007/s00216-015-8733-z Back to text
  12. National Institutes of Health Office of Dietary Supplements. Vitamin D Standardization Program (VDSP) key collaborators. Accessed August 31, 2026. Back to text
  13. Centers for Disease Control and Prevention. Improving performance: Vitamin D Standardization-Certification Program. Accessed August 31, 2026. Back to text
  14. Farrell CJ, Martin S, McWhinney B, Straub I, Williams P, Herrmann M. State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem. 2012;58(3):531-542. doi:10.1373/clinchem.2011.172155 Back to text
  15. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press; 2011. Summary. Accessed August 31, 2026. The 20 ng/mL value covers the requirement of nearly all persons under conditions of minimal sun exposure and is not a clinical decision limit. Back to text
  16. Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2024;109(8):1907-1947. doi:10.1210/clinem/dgae290 Back to text
  17. Yang DT, Cook RJ. Spurious elevations of vitamin B12 with pernicious anemia. N Engl J Med. 2012;366(18):1742-1743. doi:10.1056/NEJMc1201655 Back to text
  18. Carmel R, Agrawal YP. Failures of cobalamin assays in pernicious anemia. N Engl J Med. 2012;367(4):385-386. doi:10.1056/NEJMc1204070 Back to text
  19. Sobczyńska-Malefora A, Delvin E, McCaddon A, Ahmadi KR, Harrington DJ. Vitamin B12 status in health and disease: a critical review. Diagnosis of deficiency and insufficiency, clinical and laboratory pitfalls. Crit Rev Clin Lab Sci. 2021;58(6):399-429. doi:10.1080/10408363.2021.1885339 Back to text
  20. College of American Pathologists. Test ordering guidelines for suspected vitamin B12 and folate deficiency. Accessed August 31, 2026. Back to text
  21. US Food and Drug Administration. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Final rule. Fed Regist. 1996;61(44):8781-8797. Compliance required January 1, 1998. Back to text
  22. National Institute for Health and Care Excellence. Vitamin B12 deficiency in over 16s: diagnosis and management. NICE guideline NG239. Published March 6, 2024. Accessed August 31, 2026. Back to text
  23. Dong L, Qiu X, Gao F, Wang K, Xu X. Protein induced by vitamin K absence or antagonist II: experience to date and future directions. Biochim Biophys Acta Rev Cancer. 2023;1878(6):189016. doi:10.1016/j.bbcan.2023.189016 Back to text
  24. Evans DC, Corkins MR, Malone A, et al; ASPEN Malnutrition Committee. The use of visceral proteins as nutrition markers: an ASPEN position paper. Nutr Clin Pract. 2021;36(1):22-28. doi:10.1002/ncp.10588 Back to text
  25. American Society for Parenteral and Enteral Nutrition. Appropriate use of visceral proteins in nutrition screening and assessment. ASPEN practice tool. Accessed August 31, 2026. Back to text
  26. Davis CJ, Sowa D, Keim KS, Kinnare K, Peterson S. The use of prealbumin and C-reactive protein for monitoring nutrition support in adult patients receiving enteral nutrition in an urban medical center. JPEN J Parenter Enteral Nutr. 2012;36(2):197-204. doi:10.1177/0148607111413896 Back to text
  27. Taylor BE, McClave SA, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition. Crit Care Med. 2016;44(2):390-438. doi:10.1097/CCM.0000000000001525 Back to text
  28. Lippi G, Salvagno GL, Montagnana M, Brocco G, Guidi GC. Influence of short-term venous stasis on clinical chemistry testing. Clin Chem Lab Med. 2005;43(8):869-875. doi:10.1515/CCLM.2005.146 Back to text
  29. Cederholm T, Jensen GL, Correia MITD, et al; GLIM Core Leadership Committee; GLIM Working Group. GLIM criteria for the diagnosis of malnutrition: a consensus report from the global clinical nutrition community. Clin Nutr. 2019;38(1):1-9. doi:10.1016/j.clnu.2018.08.002 Back to text
  30. White JV, Guenter P, Jensen G, Malone A, Schofield M; Academy of Nutrition and Dietetics Malnutrition Work Group; ASPEN Malnutrition Task Force; ASPEN Board of Directors. Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition). JPEN J Parenter Enteral Nutr. 2012;36(3):275-283. doi:10.1177/0148607112440285 Back to text
  31. da Silva JSV, Seres DS, Sabino K, et al; Parenteral Nutrition Safety Committee and Clinical Practice Committee. ASPEN consensus recommendations for refeeding syndrome. Nutr Clin Pract. 2020;35(2):178-195. doi:10.1002/ncp.10474 Back to text
  32. Centers for Medicare & Medicaid Services. CLIA proficiency testing regulations and calibration verification guidance, QSO-25-10-CLIA. Revised June 23, 2025. Accessed August 31, 2026. Back to text
  33. Gloucestershire Hospitals NHS Foundation Trust. Active B12 (Holotranscobalamin). General information: active B12 use and the NG239 pregnancy pathway. Accessed September 13, 2026. This is a UK laboratory pathway. It says nothing about US utilization. Back to text

Chemistry, lesson 15 of 17

End of Vitamins and Nutrition

Practice this lesson

Back to top
More about this lesson